Detalhe da pesquisa
1.
Refractory mixed proliferative and membranous lupus nephritis treated with the topoisomerase I inhibitor irinotecan as add-on therapy.
Scand J Rheumatol
; 51(3): 237-240, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34726116